ADVERTISEMENT
News
Superpotent Antibiotic Recalled
07/29/2020
The recall affects cefdinir for oral suspension, 250 mg/5 mL, packaged in 60-mL bottles (NDC 68180-723-20) from lots F802189 (Exp. 10/20) and F900240 (Exp. 1/21). The bottles were distributed throughout the United States.
Lupin Pharmaceuticals initiated the recall July 2, 2020. The FDA designated the recall Class II on July 23, 2020. Drugs affected by Class II recalls may cause temporary or medically reversible adverse health consequences if used. While remote, a possibility of serious harm also exists.
Cefdinir is a prescription cephalosporin antibiotic used to treat bacterial infections.
—Jolynn Tumolo